April 30- May 1, 2018
Boston, MA


Conference Day One
Monday, April 30 2018

Conference Day Two
Tuesday, May 1 2018

Coffee & Registration

Chair’s Opening Remarks

R&D Procurement Evolution

Opening Address: The Ultimate Objectives of R&D Procurement – It’s Not Cost, Speed & Quality!

  • Eric Shobe VP Global Procurement, Worldwide Research & Development (WRD) & Medical, Pfizer


  • Understanding the current challenges of R&D within pharma
  • Aligning procurement’s approach to help R&D overcome those challenges
  • Managing the paradox between compliance, financial targets and R&D’s goals
  • Why R&D Procurement is key to the future of pharma

Is R&D Procurement a Privilege to Big Pharma?

  • Juan Lepe Director of Procurement R&D &Technology Category Lead, Alnylam Pharmaceuticals


  • Decrypting the myth of R&D Procurement is a privilege to large organizations
  • The rise of virtual biotechs and virtual R&D operations, the increased need of having a dedicated expert to manage R&D suppliers and activities
  • Focus on opportunities – how can you maximize value to your scientific team?

Speed Networking & Morning Coffee

Rebuild Your Sourcing & Procurement Strategy

EDC Case Study

  • Rinaldo Dorman Clinical & Medical Category Lead, R&D Procurement, Shire


  • Driving value in the form of operational efficiency
  • Using this to improve partnerships

Panel Discussion: What Innovations Do R&D Procurement Business Model Need

  • Limor Glick Director of Strategic Sourcing – R&D & Clinical Outsourcing, Sunovion
  • Mike Sandoval President & CEO, XEO Pharma
  • Raymond Alsko Director Sales & Key Accounts North America, Wavelength Pharmaceuticals


Based on the first two sessions, you can ask the speakers and wider group on their vision for the future and build a clear idea of how you need to adapt your R&D Procurement function to get ready for the transformation! 

Lunch & Networking Break

Insourcing or Outsourcing – That’s Your Question


  • The big debate – in- or outsource?
  • Case example of comparing and contrasting decision rationale: ADC
  • Building a relationship with your suppliers to minimize risks

How Pharma can Use Technology to Remain Competitive – When Everyone is Rushing to Biotech


  • Speakers will discuss the challenges the pharma industry is facing with regard to declining R&D productivity and present new technology solutions that would help address this.
    • Learn how Science Exchange can help procurement teams achieve over 56% direct cost savings per statement of work
    • Case study of significant increase of scientists’ productivity
    • The key to remain innovative in the biotech industry – improved scientific innovation by having greater and more efficient access to cutting-edge technologies

Driving Transformative Change in Pre-Clinical Support Inputs to Deliver an Efficient R&D Program

  • Gerard Cardillo Executive Director, Global Categories Procurement, Charles River Labs


  • Key drivers and inputs for pre-clinical category management
  • Defining vision and translating our strategy for an end-to-end category management
  • Transition from tactical buying to forging strategic partnerships – setting the right framework and overcoming challenges

Reflections & Actions


Based on the sessions this morning, audience will have the opportunity to reflect and discuss on actionable points in a round-table format.

Delegates will be able to choose one of the following tracks to exchange ideas. The goal is to share one key takeaway at the end of the discussion.

  • How should the future R&D Procurement organizational chart look like?
  • Supplier diversity – what’s the best practice?
  • How should you ‘manage’ your suppliers? Explore a new partnership model from early discovery through clinical trial Ph3

Joined by speakers of the day

Afternoon Tea & Networking Break

What Does Strategic Sourcing Mean to You and Your R&D Program? Biogen’s Success Story


  • How streamlined sourcing can provide additional value to the scientific teams?
  • The trend of strategic sourcing to category management

The Big Dollar Sign: Manage Your Tail Spend


  • It’s all about incremental savings – turn your tail spend into operational advantage
  • Gaining visibility of your in- and out-goings: Increase spend under management
  • From data to actions: Identify strategies to tackle spend at a category or supplier level
  • From actions to strategy: Redefine your category and sourcing tactics

Session reserved for tech partner

Chair’s Closing Remarks & Close of Day One

Private Networking Dinner


Hosted by our Lead Partner, Science Exchange – by invitation only